A proline rich antigen (PRA), which protects mice against Coccidioides immitis, has been analyzed for differential expression and variation among isolates. Northern blots of RNA from different stages of growth were probed with previously cloned cDNA and showed that mRNA for PRA increased as spherules transformed and matured from mycelia. This pattern corresponds to the relative potency of whole cell vaccines from similar preparations. The PRA gene was then cloned from a genomic library of the Silveira strain of C. immitis and its sequence analyzed. Eight other coccidioidal isolates, selected for diversity in geographic origin and resulting clinical disease, demonstrated heterogeneity in Southern blots and in sequences of polymerase chain reaction products. Silveira differed from other California isolates at 33 of 555 bases, whereas it differed from non-California isolates by р2 bases. Only one of these substitutions affected protein sequence. Thus, tests or vaccines based on this gene are likely to cover most isolates.
A proline rich antigen (PRA), which protects mice against Coccidioides immitis, has been analyzed for differential expression and variation among isolates. Northern blots of RNA from different stages of growth were probed with previously cloned cDNA and showed that mRNA for PRA increased as spherules transformed and matured from mycelia. This pattern corresponds to the relative potency of whole cell vaccines from similar preparations. The PRA gene was then cloned from a genomic library of the Silveira strain of C. immitis and its sequence analyzed. Eight other coccidioidal isolates, selected for diversity in geographic origin and resulting clinical disease, demonstrated heterogeneity in Southern blots and in sequences of polymerase chain reaction products. Silveira differed from other California isolates at 33 of 555 bases, whereas it differed from non-California isolates by р2 bases. Only one of these substitutions affected protein sequence. Thus, tests or vaccines based on this gene are likely to cover most isolates.
Coccidioidomycosis, the systemic infection caused by the dimorphic fungus Coccidioides immitis, produces a spectrum of illnesses ranging from mild and self-limited to fulminant and life-threatening. Since spontaneous recovery is usual and results in lifelong immunity to reinfection, the search for an effective vaccine has been underway for several decades.
A formalin-killed whole cell spherule vaccine, which effectively protects against experimental coccidioidal infection, has been extensively studied and produces in mice virtually complete protection against subsequent lethal coccidioidal infection [1] . This whole cell vaccine also induces a great deal of local inflammation at the injection site, limiting the dose in humans to 1.84 mg. For a person of average size, this is ∼0.001 of the milligram-per-kilogram vaccine dose required for protection in mice. When this dose was used in a human field trial, vaccination failed to result in fewer symptomatic cases of coccidioidal pneumonia than were detected in placebo recipients [2] . One plausible explanation for the failure is that the inflammatory reactions of the whole cell vaccine prevented using a sufficient dose of the antigens responsible for protection. This interpretation has refocused coccidioidal vaccine development on characterization of specific antigens by fractionation of whole cells or by cloning and expression of the responsible genes.
One protein of particular interest is a proline-rich antigen (PRA) from the coccidioidal cell wall, primarily from that of the parasitic spherule phase [3] . This antigen stimulates T cells from persons who have previously experienced self-limited coccidioidal infections. Moreover, antibody concentrations against PRA are highest in patients with extensive or progressive infections [3] [4] [5] . We have cloned and sequenced the cDNA encoding PRA, which, like the native protein, reacts with antibodies in sera from patients with progressive forms of coccidioidomycosis [6, 7] . Recently, the recombinant antigen has been demonstrated to confer protection against experimental intraperitoneal coccidioidal infection in mice [8] .
Since there is considerable morphologic, virulence, and genomic diversity among different isolates of C. immitis [9] [10] [11] , it is important to characterize the variation of any antigen that might be included in a subcellular candidate vaccine. Here we present the results of this analysis of the PRA gene sequence from isolates selected from geographically and clinically diverse sources. In addition, we examined gene expression during the transition of arthroconidia to spherules for comparison with the recognized differences in potency of whole cell vaccines prepared from various phases of growth [1] . and 1997. Isolates VFC019 and VFC036 were isolated from patients infected with human immunodeficiency virus. Strains Silveira, VFC019, VFC036, and B3108 produced pulmonary illness, whereas strain 46 and isolate B3156 produced extrapulmonary infection. Other isolates were the gift of G. Koenig (Roche Laboratories, Berkeley, CA). All manipulations of viable preparations were done under biocontainment level 3 safety procedures.
Materials and Methods

Isolates
Genomic library construction. Arthroconidia of strain Silveira (2 ϫ 10 6 ) were grown in 2ϫ glucose-yeast extract for 45 h at 37ЊC and 180 rpm. Mycelia were recovered by filtration, frozen in liquid nitrogen, pulverized in a mortar under liquid nitrogen, and transferred to a centrifuge tube containing 2.5 vol of lysis buffer (50 mM Tris, pH 7.6, 100 mM NaCl, 50 mM EDTA, 5% SDS, and 10 mM 2-mercaptoethanol). Particulate material was pelleted (1500 g for 15 min), and the DNA was recovered from the supernatant by phenol extraction, followed by repeated chloroform extraction and ethanol precipitation [12] .
Genomic DNA (10 mg) was digested with MboI, ligated into the XhoI half-sites of l GEM11 (Promega, Madison, WI), packaged with Gigapack III Gold Packaging Extract (Stratagene, La Jolla, CA), as suggested by the vendors, and transformed into Escherichia coli KW 251 (Promega). The library contained plaques or 5 6 ϫ 10 roughly 300 copies of the genome (genome equivalents, based on a genome of 29 Mb [13] ).
Screening of the genomic library. A 501-bp probe of the PRA gene was generated by polymerase chain reaction (PCR) from pCiAg33.41 [6] using primers 8716 (5 -CCAATTGACATC-CCACCA) and 8718 (5 -GAGAGGGGAGAGCAGAGA). The amplimer was labeled with digoxigenin-11-dUTP (DIG DNA Labeling and Detection kit; Boehringer Mannheim, Indianapolis) and used to screen the C. immitis genomic library, following the manufacturer's protocol.
Isolation of the PRA gene. PRA-hybridizing clones were purified and phage DNA was isolated by standard methods [12] . Phage DNA was digested with SacI to yield several fragments, which were subcloned into pBluescript SK(ϩ).
DNA sequencing. Plasmid and/or phage DNA was sequenced in both directions on an automated DNA sequencer (ABI 377; Applied Biosystems, Foster City, CA). Sequencing primers were synthesized and automated sequencing done at the Macromolecular Structures Facility, Arizona Research Laboratories, University of Arizona.
Southern and Northern blot analysis. For Southern blot analysis, fungal DNA was isolated by disrupting ∼100 mg of mycelium with 0.5-mm glass beads in 1.2 mL of lysis buffer. The lysate was extracted with phenol-chloroform three times and the DNA was ethanol-precipitated. DNA (10 mg) from each strain was digested with BamHI, XhoI, or EcoRI (Stratagene) and electrophoresed into a 0.75% agarose gel, and the DNA was transferred by vacuum blotting to a nylon membrane. The 501-bp PRA gene PCR product was labeled with [ 32 P]dCTP (RadPrime kit; BRL, Gaithersburg, MD), hybridized to the blot for 16 h at 68ЊC, and washed [12] .
For Northern blot analysis, RNA was isolated from spherules (Silveira strain) grown in Converse medium and harvested after varying times [3] . Mycelia were harvested from a 48-h liquid culture as above. Total RNA was extracted in two steps, with 6 M guanidine isothiocyanate and hot phenol, followed by RNAid (Bio 101, Vista, CA), as described [6] . About 30 mg of total RNA was loaded per lane for denaturing agarose gel electrophoresis. The blot was probed as described above, and the signal was normalized to the signal produced by a probe corresponding to g-actin on a phosphoimager (445 SI; Molecular Dynamics, Milpitas, CA). The actin probe was generated by reverse transcriptase-PCR using RNA from coccidioidal mycelia as template and primers designed by alignment of several fungal actin sequences (Aspergillus nidulans, Histoplasma capsulatum, and Neurospora crassa; sequences available from the authors).
PCR and direct sequence determination. To determine the nucleotide sequence of PRA for each strain, primers P33 (5 -TC-TCTCACGCTCTCATCG) and P35 (5 -CAGCACCTGGGAA-CTCAG) were used to amplify a segment of DNA corresponding to most of the coding region of the PRA gene. The product was isolated (QIAquick gel extraction kit; QIAGEN, Chatsworth, CA) and was directly sequenced with primers P33 and P35 as above. The sequence was verified in two independent experiments.
Results
Cloning and sequence analysis of the PRA gene. Of eight positive clones detected by primary screening of the genomic library, one was retained for further analysis. A 3.8-kb SacI/ SacII fragment, containing 736 bp upstream from the tsp [6] and 1695 bp downstream from the polyadenylation signal, was sequenced in both directions. Possible 5 regulatory sequences, including a TATA box (Ϫ36 bp), canonical CAAT boxes (Ϫ242 bp and Ϫ272 bp), Sp1 motifs (Ϫ50 bp, Ϫ142 bp, and Ϫ397 bp), and a core A (GT-IIC) motif (Ϫ537 bp), were noted. There were two introns confirmed to be 78 bp and 102 bp, respectively, and intron/exon splice junctions exactly followed the GT/AG rule [14] . The complete nucleotide sequence of this fragment has been deposited in GenBank (accession no. AF013256).
Southern blot analysis. The gene appeared to be present as a single copy, based on Southern blot analysis of genomic DNA from 9 strains of C. immitis used in this study. There was a considerable degree of restriction fragment length polymorphism (RFLP) around the PRA gene, as determined on the basis of known proximal BamHI sites in the Silveira sequence (figure 1). At this level of resolution, 5 different groups could be inferred. Strain Silveira (lane 1) appeared to differ from all other strains. Two California strains (lanes 8 and 9) formed a second group. Isolates from Tucson and Texas formed 3 additional groups (lanes 2, 4, and 6; lanes 3 and 7; and lane 5 as distinct, respectively). Restriction with either EcoRI or HindIII did not further distinguish members within these groups (data not shown).
We used PCR amplification and direct cycle sequencing to assess nucleotide differences in the region encoding the openreading frame (table 1). Nucleotide differences were evident in both the coding region and introns among the various strains. The 2 California strains (C-46, VFC043) differed considerably from Silveira, 4 Tucson isolates (B3156, B3108, VFC019, and VFC036), an Argentinian isolate (VFC044), and a Texas isolate (2127). However, none of these differences affected the polypeptide sequence, except for a single-amino acid substitution Nucleic acids Silveira
NOTE. Numbers indicate positions in Silveira nucleotide sequence from translation start codon of PRA gene; 7, nucleotides or amino acids identical to Silveira sequence; Ϫ, deletion; * , no amino acids in intron. 82-159 and 299-400 are introns. Isolates were recovered from patients in a California, b Arizona, c Argentina, or d Texas.
at the 91st position, where aspartic acid was replaced by glutamic acid in the 2 California isolates. Northern blot analysis. Under the conditions used for in vitro spherule growth, barrel-shaped arthroconidia (3-5 mm) changed to small round cells after 24 h. By 48 h, they had grown on average to 8 mm, and internal septa had begun to form. By 96 h, the fully mature spherule averaged 12 mm in diameter but could be as large as 19 mm, with many internal septa surrounding endospores. At this stage, a few spherules had ruptured and had released endospores. With spherule maturation, PRA mRNA increased. Whereas for mycelia, the ratio of PRA to actin mRNA was 2.6, this changed to 3.7, 4.1, 5.9, and 8.1 for 24-h, 48-h, 72-h, and 96-h spherules, respectively.
Discussion
In this study, we have cloned the gene for PRA from 1 strain of C. immitis and have used PCR products from other isolates to analyze allelic diversity. Strains originated from several geographic regions and were isolated in several different decades of this century. Three of the isolates were known to have come from patients with pneumonia, whereas 2 were isolated from patients with extrapulmonary dissemination. RFLP analysis was used to confirm that this group of isolates was not of an apparent commonality.
Although several base substitutions and insertions outside of the coding region were evident among the 9 isolates, only the California isolates differed from the others at the amino acid level. This involved a single-amino acid substitution, with aspartic acid replaced by glutamic acid at position 91. It is possible for T cell clones to detect single substitutions such as this [15] . On the other hand, aspartic and glutamic acids are structurally similar molecules. Therefore, this difference is a relatively conservative substitution and less likely to affect the protein's overall antigenic importance. Although further studies would be useful to corroborate this assumption, our findings suggest that PRA is highly conserved among different isolates of C. immitis. As a vaccine candidate, PRA would be expected to demonstrate protection broadly across the entire species.
Analysis of the population genetics of C. immitis has suggested that isolates segregate into 2 groups, a California group and a non-California group [11, 16] . The polymorphisms in the PRA gene described in the present study are consistent with this pattern. The two isolates that originated in California were shown to differ from the others both in terms of RFLP pattern and at the nucleotide level. The Silveira strain, isolated in the San Joaquin Valley (California) in 1951, has been shown to differ from other California isolates, also in agreement with other studies [11] . Since the difference in PRA between the California and the non-California pattern appears to be slight, vaccination with PRA would likely result in similar protection against exposure to isolates from either group.
In an earlier study [3] , we used immunoelectron microscopy to estimate the amount of PRA produced in various phases of growth of C. immitis in vitro, and the level was shown to increase as a function of spherule maturity. In the present report, we showed that the amount of PRA mRNA also increases with maturity. Although there is some variation in the developmental stages that are isolated from culture at a given time point, the trend toward increased PRA transcription is clear. The putative regulatory elements noted in the 5 untranslated region may be significant in modifying the expression of PRA. Future studies targeting this region for mutation could be helpful to understand PRA expression and its regulation.
